rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Strata Critical Medical, Inc.

SRTA · Nasdaq

Health CareProviders & FacilitiesNot moving yet

SRTA stood above a rising 150-day average in 31 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 12.8% below that average now. Providers & Facilities: 43% of its 53 stocks in an uptrend (−4 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 3
Industry in uptrend
43% -4 in 4 wk
Insider buys, 12 months
$98K
Insider sales, 12 months
$1.8M
Officials’ trades on record
0
Institutions holding
135 (+17)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 31 of 52 weeks.

20 Apr – 19 Oct
27%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$7.3M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months10
Buyers · sellers2 · 5
WhoDidSharesTraded
Reginald LoveDirectorsold5,091at $5.7510 Aug 2026filed 13 Aug 2026
Scott M. WunschCEO, Logisticssold5,550at $5.878 Jun 2026filed 10 Jun 2026
Melissa M. TomkielCo-CEO and General Counselsold29,730at $5.878 Jun 2026filed 10 Jun 2026
Amir CohenChief Accounting Officersold4,655at $5.878 Jun 2026filed 10 Jun 2026
William A. HeyburnCo-CEO and CFOsold31,671at $5.878 Jun 2026filed 10 Jun 2026
Amir CohenChief Accounting Officersold40,575at $5.9122 May 2026filed 26 May 2026
Amir CohenChief Accounting Officersold10,300at $5.7921 May 2026filed 26 May 2026
Amir CohenChief Accounting Officersold14,306at $5.7911 May 2026filed 13 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders135+17 on the quarter
New · exited32 · 16
Reported value$280.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Third Point LLCunchanged · filed 14 Aug 20265,000,000$26.4M00.0%
Northern Right Capital Management, L.P.added · filed 14 Aug 20264,890,584$25.8M+800,415+19.6%
BlackRock, Inc.added · filed 7 Aug 20264,835,516$25.5M+267,248+5.9%
ROYCE & ASSOCIATES LPadded · filed 14 Aug 20263,132,933$16.5M+316,561+11.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20262,885,319$15.2M+12,873+0.4%
AWM Investment Company, Inc.unchanged · filed 14 Aug 20262,821,468$14.9M00.0%
ARK Investment Management LLCreduced · filed 14 Aug 20262,730,855$14.4M-4,724,429−63.4%
First Eagle Investment Management, LLCadded · filed 5 Aug 20262,314,614$12.2M+48,371+2.1%
Pillsbury Lake Capital LLCreduced · filed 14 Aug 20262,171,006$11.4M-432,790−16.6%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,755,383$9.3M+55,673+3.3%
31 Mar 2023 – 30 Jun 2026
80107133Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Melissa M. Tomkiel Company insiderCo-CEO and General Counsel · last 24 Sep 20260 · 25
William A. Heyburn Company insiderCo-CEO and CFO · last 24 Sep 20261 · 25
Amir Cohen Company insiderChief Accounting Officer · last 8 Sep 20260 · 26
Louis R. Verdetto Company insiderCEO, Clinical Services · last 8 Sep 20260 · 0
Scott M. Wunsch Company insiderCEO, Logistics · last 8 Sep 20260 · 2
Reginald Love Company insiderDirector · last 10 Aug 20261 · 5
Andrew Lauck Company insiderDirector · last 30 Jul 20261 · 0
Edward M. Philip Company insiderDirector · last 30 Jul 20260 · 0
Robert S. Wiesenthal Company insiderDirector · last 30 Jul 20260 · 16
William L. Cook III Company insiderDirector · last 30 Jul 20260 · 0
Velibor Krstic Company insider10% owner · last 7 May 20260 · 0
Eric Affeldt Company insiderDirector · last 1 Aug 20252 · 0

Same industry

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202520.9%
Operating profit marginFY 2025 · to 31 Dec 2025-11.3%
Free cash flow marginFY 2025 · to 31 Dec 2025-29.7%
Return on capital employedFY 2025 · to 31 Dec 2025-7.3%
Cash conversionFY 2025 · to 31 Dec 2025-118%
Share count trendFY 2025 · to 24 Feb 20266.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$31.0M
Free cash flowFY 2025 · to 31 Dec 2025−$58.5M

Analyst forecasts

No analyst forecasts yet.